News

MISSOULA, Mont. — Time is running out to use the $1.25 billion Montana received in CARES Act money. Now, the majority of the country’s attorneys general signed on to a letter pushing for an extension. Montana Attorney General Tim Fox signed on to the letter, along with 42 other attorneys general, urging Congress to extend the deadline to use the funds until the end of next year. “We now know that, you know, things may not be back to normal until some time next year,” Fox said. “We felt like that deadline was somewhat artificial and inappropriate and that we

HELENA- Montana is going to receive 264 vials of Regeneron casirivimab/imdevimab cocktail and 370 vials of bamlanivimab. The first shipments of Regeneron’s antibody therapeutic, casirivimab and imdevimab are going to start to be received according to a release from Senator Steve Daines. The release says Regeneron’s antibody cocktail is authorized for the treatment of non-hospitalized mild to moderate COVID-19 cases in adults and children 12 years and older who are at high risk for progressing to severe COVID-19 and/or hospitalization.

MISSOULA, Mont. — Operation Warp Speed means progress on COVID-19 vaccinations is moving fast, and state officials this week unveiled a draft plan of how initial vaccination distribution might look in Montana — but there is still a lot up in the air. The state’s vaccination plan is a draft based on a CDC playbook released in October. Part of it includes education and messaging to encourage folks to get the vaccine, which is something the country’s top infectious disease expert, Dr. Anthony Fauci, emphasized in an exclusive NBC Montana interview Monday. “We need to articulate what actually happens. And

HELENA — State officials said they are looking at a three-phased approach to provide vaccinations in Montana that includes getting the much-expected COVID-19 vaccines to frontline health care and other health care workers, high-risk populations and eventually to members of the general public who want it. The Department of Public Health and Human Services on Tuesday had the first meeting of a COVID-19 Vaccination Plan Coordination Team comprised of more than 60 people from key groups statewide. Plans are to ship the vaccines directly to the areas where they will be distributed.Pfizer recently asked the U.S. Food and Drug Administration

A great hope was announced to the world this week when we learned that a potential vaccine for COVID-19 is on the immediate horizon. Pharmaceutical giant Pfizer said its vaccine is 95% effective against the virus that has infected some 11 million U.S. residents and killed more than 250,000 since February. The company is asking federal regulators to allow emergency use of the vaccine, meaning shots could be available on a limited scale as early as next month. Globally, Pfizer has estimated it could have 50 million doses available by year’s end. Meanwhile, drugmaker Moderna says its vaccine is equally

Sen. Steve Daines, R-Mont., discuses his experience in the trial, calls recent vaccine news ‘very promising.’

U.S. Senator Steve Daines announced earlier this week his participation in Pfizer’s COVID-19 vaccine trial and that he has since tested positive for COVID-19 antibodies. “The only way we’re going to end this pandemic is by getting a vaccine out to the American people,” Senator Daines said via phone to Wake Up Montana. Pfizer says their vaccine 95% effective and is seeking the FDA emergency use authorization. “My mom told me about it,” Senator Daines said, “my parents live in Bozeman and my mom was made aware of the Pfizer trial being administered by Bozeman Health… so Cindy (the senator’s

Republican Sen. Steve Daines of Montana on Friday urged Americans to have confidence in the coronavirus vaccine from Pfizer and BioNTech, relying on his experience as a participant in the companies’ phase three clinical trial. The U.S. pharmaceutical giant and German biotech firm said earlier Friday they intended to apply for emergency use authorization from the U.S. Food and Drug Administration, making them the first companies to do so for a Covid-19 vaccine. Final data released this week showed the vaccine was 95% effective in preventing the disease. The FDA’s review process is expected to take a few weeks. “This